⌘K

Home/Filings/4/0001209191-21-014543

4//SEC Filing

Evanson Jeff 4

Accession 0001209191-21-014543

CIK 0001649989other

View on SEC.gov Company Profile

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 8:52 PM ET

Size

4.9 KB

Accession

0001209191-21-014543

Insider Transaction Report

Form 4

Period: 2021-02-23

Outlook Therapeutics, Inc.OTLK

Chief Commercial Officer

Transactions

Sale
Common Stock
2021-02-23$2.09/sh−8,554$17,861→ 1,141,930 total

Footnotes (1)

[F1]These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 25% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Outlook Therapeutics, Inc.

CIK 0001649989

Entity typeother

Related Parties

1

filerCIK 0001760511

Filing Metadata

Form type: 4
Filed: Feb 24, 7:00 PM ET
Accepted: Feb 25, 8:52 PM ET
Size: 4.9 KB

View on SEC.gov